OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
23 hedge funds and large institutions have $10.3M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.12M | |
| 2 | +$1.04M | |
| 3 | +$356K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$29.7K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.6K |
Top Sellers
| 1 | -$827K | |
| 2 | -$354K | |
| 3 | -$352K | |
| 4 |
BCM
Brasada Capital Management
Houston,
Texas
|
-$295K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$223K |